New frontiers in biomarkers for hepatocellular carcinoma
Authors:
- 30 November 2006
- journal article
- review article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 38 (11) , 854-859
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Hepatocellular carcinoma in cirrhosis: Incidence and risk factorsGastroenterology, 2004
- The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An UpdateAnnals of Internal Medicine, 2003
- Estimating the world cancer burden: Globocan 2000International Journal of Cancer, 2001
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Estimating future hepatitis C morbidity, mortality, and costs in the United StatesAmerican Journal of Public Health, 2000
- Cirrhosis mortality and per capita consumption of distilled spirits, United States, 1949-94: trend analysisBMJ, 1999
- Rising Incidence of Hepatocellular Carcinoma in the United StatesNew England Journal of Medicine, 1999
- Liver Transplantation for Hepatocellular CarcinomaSeminars in Liver Disease, 1999
- Treatment of Hepatocellular Carcinoma Associated with Cirrhosis in the Era of Liver TransplantationAnnals of Internal Medicine, 1998
- Trends of liver cirrhosis mortality in Europe, 1970-1989: age-period-cohort analysis and changing alcohol consumption.International Journal of Epidemiology, 1997